DR. JURRIEN DEAN, M.D.
Osteopathic Medicine at Hampden Ln, Bethesda, MD
License number
Maryland D0022265
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
7422 Hampden Ln, Bethesda, MD 20814
Phone
(301) 656-1227
Personal information
See more information about JURRIEN DEAN at radaris.comName
Address
Phone
7422 Hampden Ln, Bethesda, MD 20814
Chevy Chase, MD
7422 Hampden Ln, Bethesda, MD 20814
Organization information
See more information about JURRIEN DEAN at bizstanding.comJurrien Dean MD
9000 Rockville Pike, Bethesda, MD 20892
Industry:
Internist
Phone:
(301) 496-6125 (Phone)
Jurrien Dean
National Institutes Of Health - Jurrien Dean MD
9000 Rockville Pike #50-3133, Bethesda, MD 20892
Categories:
Internal Medicine Physicians & Surgeons
Phone:
(301) 496-6125 (Phone)
Professional information
Jurrien Dean, Bethesda MD
Specialties:
Internal Medicine, Surgery
Work:
National Institutes Of Health
9000 Rockville Pike, Bethesda, MD 20892
9000 Rockville Pike, Bethesda, MD 20892
Education:
Columbia University (1973)
Dr. Jurrien Dean, Bethesda MD - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
7422 Hampden Ln, Bethesda 20814
(301) 656-1227 (Phone)
(301) 656-1227 (Phone)
Certifications:
Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1973
New York-Presbyterian Hospital
Johns Hopkins
Columbia University / College of Physicians And Surgeons
Graduated: 1973
New York-Presbyterian Hospital
Johns Hopkins
Contraceptive Vaccine Based On Alloimmunization With Zona Pellucida Polypeptides
US Patent:
5916768, Jun 29, 1999
Filed:
May 23, 1997
Appl. No.:
8/862903
Inventors:
Jurrien Dean - Bethesda MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
C12P 2106, C12N 700, C07H 1900, C07H 1901
US Classification:
435 693
Abstract:
The present invention relates to contraceptive vaccines based on cloned zona pellucida genes and the strategy of alloimmunization with zona pellucida polypeptides. In particular, the present invention relates to a contraceptive vaccine for use in a mammalian female comprising a polypeptide which displays at least one epitope for binding of an antibody that inhibits fertilization of an oocyte by a sperm. This epitope is from a zona pellucida procein of the species in which the said vaccine is used. This invention relates, more particularly, to such vaccines wherein the zona pellucida protein is either the ZP3 or the ZP2 or the ZP1 protein or the mouse or homologues of these proteins in some other mammalian species. Further, this invention comprehends vaccines comprising a synthetic peptide that displays an epitope for such an antibody that inhibits fertilization. In addition, this invention relates to cloned DNA segments variously encoding the mouse ZP3 or ZP2 proteins or the human ZP3 or ZP2 protein.
Contraceptive Vaccine Based On Alloimmunization With Zona Pellucida Polypeptides
US Patent:
5641487, Jun 24, 1997
Filed:
Mar 26, 1993
Appl. No.:
8/038948
Inventors:
Jurrien Dean - Bethesda MD
Assignee:
The Government of the United States of America as represented by the
Secretary Department of Health and Human Services - Washington DC
Secretary Department of Health and Human Services - Washington DC
International Classification:
A61K 3900, A61K 3800, C12P 2104, C07K 200
US Classification:
4241841
Abstract:
The present invention relates to contraceptive vaccines based on cloned zona pellucida genes and the strategy of alloimmunization with zona pellucida polypeptides. In particular, the present invention relates to a contraceptive vaccine for use in a mammalian female comprising a polypeptide which displays at least one epitope for binding of an antibody that inhibits fertilization of an oocyte by a sperm. This epitope is from a zona pellucida protein of the species in which the said vaccine is used. This invention relates, more particularly, to such vaccines wherein the zona pellucida protein is the ZP3 protein or the mouse or homologues of the protein in some other mammalian species. Further, this invention comprehends vaccines comprising a synthetic peptide that displays an epitope for such an antibody that inhibits fertilization. In addition, this invention relates to cloned DNA segments variously encoding the mouse ZP3 protein or the human ZP3 protein.
Contraceptive Vaccine Based On Alloimmunization With Zona Pellucida Polypeptides
US Patent:
5672488, Sep 30, 1997
Filed:
May 30, 1995
Appl. No.:
8/453952
Inventors:
Jurrien Dean - Bethesda MD
Assignee:
The United States of America as represented by the Secretary, Department
of Health and Human Services - Washington DC
of Health and Human Services - Washington DC
International Classification:
C12P 2106, C12N 700, C07H 1900, C07H 1901
US Classification:
435 693
Abstract:
The present invention relates to contraceptive vaccines based on cloned zona pellucida genes and the strategy of alloimmunization with zona pellucida polypeptides. In particular, the present invention relates to a contraceptive vaccine for use in a mammalian female comprising a polypeptide which displays at least one epitope for binding of an antibody that inhibits fertilization of an oocyte by a sperm. This epitope is from a zona pellucida protein of the species in which the said vaccine is used. This invention relates, more particularly, to such vaccines wherein the zona pellucida protein is either the ZP3 or the ZP2 or the ZP1 protein or the mouse or homologues of these proteins in some other mammalian species. Further, this invention comprehends vaccines comprising a synthetic peptide that displays an epitope for such an antibody that inhibits fertilization. In addition, this invention relates to cloned DNA segments variously encoding the mouse ZP3 or ZP2 proteins or the human ZP3 or ZP2 protein.
Contraceptive Vaccine Based On Alloimmunization With Zona Pellucida Polypeptides
US Patent:
5626846, May 6, 1997
Filed:
May 30, 1995
Appl. No.:
8/453472
Inventors:
Jurrien Dean - Bethesda MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Rockville MD
and Human Services - Rockville MD
International Classification:
A61K 3900, A61K 3800, C12P 2104, C07K 200
US Classification:
4241841
Abstract:
The present invention relates to contraceptive vaccines based on cloned zona pellucida genes and the strategy of alloimmunization with zona pellucida polypeptides. In particular, the present invention relates to a contraceptive vaccine for use in a mammalian female comprising a polypeptide which displays at least one epitope for binding of an antibody that inhibits fertilization of an oocyte by a sperm. This epitope is from a zona pellucida protein of the species in which the said vaccine is used. This invention relates, more particularly, to such vaccines wherein the zona pellucida protein is either the ZP3 or the ZP2 or the ZP1 protein or the mouse or homologues of these proteins in some other mammalian species. Further, this invention comprehends vaccines comprising a synthetic peptide that displays an epitope for such an antibody that inhibits fertilization. In addition, this invention relates to cloned DNA segments variously encoding the mouse ZP3 or ZP2 proteins or the human ZP3 or ZP2 protein.
Osteopathic Medicine licenses in Maryland
CARYN GEE MORSE, Osteopathic Medicine, 9000 Rockville Pike Building 10 ROOM 5A06, Bethesda, MD 20892